Blood Chemistry Testing - Cost Per Reportable Result

This is a Request for Quote (RFQ) for commercial products and commercial services, specifically for a clinical chemistry analyzer. The Government will award to the responsible offeror with the most advantageous offer, considering technical and price factors. Offerors must demonstrate their analyzer meets the requirements outlined in Exhibit A - Contract Requirements and Exhibit B - Blood Chemistry Estimated Annual Workloads, including onsite training, method verification, and service/maintenance. A key requirement is the ability to begin patient testing no later than 01 March 2026. Offers will be evaluated on their ability to explain processes and procedures, and option prices will be assessed for balance. Additionally, this contract incorporates the Protection of Human Subject Research clause (DFARS 252.235-7004) if human subject research is involved, and offerors are responsible for any costs associated with breaches of PII/PHI. Questions regarding the RFQ were due by November 13, 2025, at 15:00 Central European Time.

Notice ID

3e6ee17ffa084c5bbcac476a9dc67046

Solicitation Number

W9114F-26-Q-A010

NAICS Code

325413

Classification Code

6550